Delivery Order SPE2DB20D3103-SPE2DB24FP9G7
Award Date
8/16/24
Potential Completion Date
8/19/24
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $68,193.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp for the supply of Pulmozyme 1 mg/ml ampules (2.5 ml). The contract has a firm fixed price and an ultimate completion date of August 14, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order under its Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,579.81 firm-fixed-price delivery order is for the supply of Pulmozyme 1 mg/ml ampules, a medication used in the treatment of cystic fibrosis. The award has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,167.20 firm fixed-price delivery order is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a medical product, with a completion date of January 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,750.80 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pulmozyme 1 mg/ml ampul 2.5 ml. The contract has a ceiling value of $31,801.68 and is a firm-fixed-price delivery order with a completion date of September 13, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,817.78, is for the delivery of Pulmozyme 1 mg/ml ampul 2.5 ml. This is a firm-fixed-price delivery order contract with an ultimate completion date of August 26, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $77,601.82 delivery order contract is for the supply of Pulmozyme 1 mg/mL ampuls, a medication used to treat cystic fibrosis. The contract is a firm fixed-price, non-set-aside award with a performance period ending on April 29, 2025. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery...
This federal contract award, valued at $13,357.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The award is for a delivery order to supply Pulmozyme 1 mg/ml ampul 2.5 ml, a medication used to treat cystic fibrosis. The contract has a firm fixed price and a performance period ending on April 30, 2025. This award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Pulmozyme 1 mg/ml ampul 2.5 ml, a pharmaceutical product. The contract has a firm fixed price, a ceiling value of $7,300.97, and a period of performance through June 24, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is the prime...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $17,383.50 and covers the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a specialty medication. The contract is a Firm Fixed Price Delivery Order, with a completion date of February 25, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC)...